Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Blablabla blabla......

<< Previous

Bullboard Posts

Next >>

Comment by houbahopon Sep 17, 2023 11:10am

200 Views

Post# 35640272

RE:RE:Blablabla blabla......

Nothing to buy here before major changes of members of the Board.
Also the $6m pay of the CEO needs to be drastically lowered.

Until then, this is a dead cat bounce.
Made good profits selling in the $4 last week. ;)

Also, I see major accounting adjustments in the adjusted EBITDA to make it positive.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China